Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 Diabetes
Supplemental Data
Files in this Data Supplement:
Supplemental Table 1 (.pdf, 78 KB)
- The QPCR-primers used in this study